Catalyst

Slingshot members are tracking this event:

Phase 3 REGENERATE trial full data of Ocaliva Obeticholic acid in Adult nonalcoholic steatohepatitis patients due at EASL April 11, 2019 3:15 PM CEST

Source Link:
http://ir.interceptpharma.com/news-releases/news-release-details/intercept-announces-positive-topline-results-pivotal-phase-3

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ICPT Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 11, 2019
Occurred Source:
http://ir.interceptpharma.com/news-releases/news-release-details/intercept-reports-additional-positive-data-regenerate-first
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Study, Regenerate, Ocaliva, Obeticholic Acid, Nash
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.